Understanding long-term effects of Type 1 Diabetes in patients
Official title: Clinical Characteristics of People With Long-term Type 1 Diabetes: a Cohort Study
Run by Second Xiangya Hospital of Central South University · NCT05359796 · Data updated 2026-11-12
This study is trying to learn more about the long-term effects of Type 1 Diabetes in people who have had it for at least 10 years, by looking at their health data over three years.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Second Xiangya Hospital of Central South University Academic / other |
| Locations | 1 site (Changsha, Hunan) |
| Status | Recruiting |
| Started | May 1, 2022 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2027 |
| Registry record updated | May 4, 2022 |
| Trial ID | NCT05359796 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with Type 1 Diabetes for 10 years or more who are insulin-dependent.
✕Probably not a fit
Patients with Type 2 diabetes, gestational diabetes, or other specific types of diabetes will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect clinical and laboratory data from 400 patients with Type 1 Diabetes (T1D) who have had the condition for at least 10 years. Over a period of three years, patients will be followed up annually to explore risk and protective factors associated with microvascular complications. The study will utilize regression analysis to identify these factors and ensure data accuracy through a dual-entry system for data collection. The findings aim to enhance understanding of long-term T1D characteristics, particularly in the context of the Chinese population.
Why it matters
Potential benefit: If successful, this study could lead to improved prediction and prevention strategies for microvascular complications in long-term T1D patients.
How similar studies have gone: While studies on long-term T1D exist, this specific focus on the Chinese population and the identification of protective factors is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals diagnosed with type 1 diabetes(T1D) according to the 1999 World Health Organization report * Insulin dependence from disease onset * with T1D duration of ≥10 years * able to understand the procedures and methods of this study, voluntarily participate in the study, and agree to sign the informed consent form Exclusion Criteria: * patients with type 2 diabetes, gestational diabetes, or specific types of diabetes * patients with mental disability or have any other condition or disease that may hamper compliance with the protocol
Where it's running
-
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Changsha, Hunan, China Recruiting
Study contacts
- Principal investigator: Xia Li, MD/PHD — Central South University
- Study coordinator: Xia Li, MD/PHD
- Email: lixia2014@vip.163.com
- Phone: +86 17373199692
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Semaglutide on body composition in adults with type 1 diabetes and overweight/obesity
This study tests whether weekly semaglutide changes body composition in adults with type 1 diabetes who are overweight or obese, compared with a placebo over 24 weeks.
-
Next Generation Extended Wear Sensors in Type 1 and Type 2 Diabetes
This study tests a new extended wear sensor and algorithm in people with type 1 or type 2 diabetes to see how well it works across adults and children.
-
CGM-guided carb awareness education for adults with Type 1 diabetes
This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.
-
Safety and effectiveness of GLP-1 receptor agonists and SGLT inhibitors added to insulin in adults with type 1 diabetes
This registry will see if adding GLP-1RA or SGLTi therapies to insulin helps adults with type 1 diabetes over one year.
-
Think-Find-Solve activities for insulin self-management in children with type 1 diabetes
A behavior-change activity book is tested with children aged 8–12 with type 1 diabetes and their parents to see if it improves daily insulin self-management.
-
Near-sensor insulin delivery with CGM in people with type 1 diabetes
A small early-feasibility study tests a dual-port insulin patch pump that includes a CGM sensor to see if delivering insulin near the sensor affects glucose readings and whether an automated control algorithm can manage glucose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.